Projections of the cost of cancer care in the United States: 2010-2020

Journal of the National Cancer Institute

Volumn 103, Issue 2, 2011, Pages 117-128

  Mariotto, Angela B ^a   Robin Yabroff, K ^a   Shao, Yongwu ^b   Feuer, Eric J ^a   Brown, Martin L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER THERAPY; HEALTH CARE COST; INCIDENCE; INSURANCE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR LOCALIZATION; UNITED STATES;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COST OF ILLNESS; FEMALE; FORECASTING; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MEDICAL RECORD LINKAGE; MEDICARE; NEOPLASMS; POPULATION DYNAMICS; PREVALENCE; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 79251470391     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq495     Document Type: Article

References (25)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al (eds). SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975-2005. Accessed July 2008.
2. Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-897.
3. U.S.Census Bureau, Population Division. Interim Projections Consistent With Census 2000 (released March 2004). Washington D.C.: U.S. Census Bureau, Population Division; 2008. http://www.census.gov/population/www/projections/ usinterimproj/. Accessed July 2008.
4. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626-633.
5. Fact Book Fiscal Year 2008 From the National Heart, Lung and Blood Institute (NHLBI) of the National Institute of Health. 2009. http://www.nhlbi.nih.gov/about/factbook/FactBookFinal.pdf. Accessed July 2009.
6. Schrag D. The price tag on progress-chemotherapy for colorectal cancer. N Engl J Med. 2004;351(4):317-319.
7. Mariotto AB, Yabroff KR, Feuer EJ, et al. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control. 2006;17(10):1215-1226.
8. Berkeley Mortality Database. Data downloaded on November 2007. Berkeley, CA:: University of California; 2009. http://www.demog.ber keley.edu/∼bmd/. Accessed July 2009.
9. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-18.
10. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med. 2002;21(22): 3511-3526.
11. De Angelis R. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med. 1999;18(4): 441-454.
12. Johnson NL, Kotz S. Distribution in Statistics: Continuous Univariate Distributions 1. New York, NY: John Wiley & Sons; 1970.
13. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9): 630-641.
14. Brown M, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease-specifc costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care. 1999. 43(7):637-639.
15. Yabroff KR, Warren JL, Schrag D, et al. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care. 2009;47(7 suppl 1):S56-S63.
16. Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 1995; 13(3):235-252. (Pubitemid 26022990)
17. The Henry J Kaiser Family Foundation. Health Care Costs: Key Information on Health Care Costs and Their Impact. Mento Park, CA 2009. www.kff.or g/insurance/upload/7670-02.pdf. Accessed August 2010.
18. Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev. 1997;18(4):51-76.
19. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009; 27(23):3868-3874.
20. Warren JL, Mariotto AB, Meekins A, et al. Current and future utilization of services from medical oncologists. J Clin Oncol. 2008;26(19):3242-3247.
21. Tangka FK, Trogdon JG, Richardson LC, et al. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010. 116(14):3477-3484.
22. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995; 87(6):417-426.
23. Rosen AB, Cutler DM. Challenges in building disease-based national health accounts. Med Care. 2009;47(7 suppl 1):S7-S13.
24. Kerrigan M, Howlader N, Mandelson MT, et al. Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization. Med Care. 2005;43(10):1043-1048.
25. Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003;Suppl Web Exclusives):W3-98.